Shigella infection treatment study for young children
Treatments studied
Part of Digestive system, Infections clinical trials.
This study tests how well a recommended treatment works for children aged 6 months to 5 years who have diarrhea caused by Shigella bacteria. It aims to find the best way to help children recover faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 6 months and 5 years old.
- Your child has watery diarrhea and tested positive for Shigella.
- You live in the area where the study is taking place.
- You are willing to bring your child for follow-up visits and provide samples.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new Shigella vaccine in healthy adults to see if it is safe and creates a good immune response. It is a first-in-human study, meaning this is the first time the vaccine is given to people.
This trial tests an oral vaccine designed to protect against two common causes of severe diarrhea: shigella and ETEC bacteria. Healthy adults aged 18 to 50 will receive the vaccine and later be exposed to the bacteria to see if it works.
This study looks at how antibiotics affect the immune system of malnourished infants with diarrhea. It aims to understand if unnecessary antibiotics might harm the body's ability to fight off infections.
This study compares three different antibiotics to treat small intestine bacterial overgrowth (an overgrowth of bacteria in the gut) in children in Bangladesh. It aims to find which antibiotic works best.
This study tests a new vaccine designed to protect against shigella, a bacteria that causes severe diarrhea. It is being tested in healthy adults, children, and infants to see if it is safe and how well it boosts the immune system.
This Phase 1 study gives a carefully measured dose of Shigella sonnei to healthy adults to learn about the infection’s safety and how the body responds. It may help researchers build safer future tests or treatments, but it requires a hospital stay and many follow-up visits.
Hear when a new Diarrhea Infectious trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.